TAK-901 Uses, Dosage, Side Effects and more
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
| Trade Name | TAK-901 |
| Generic | TAK-901 |
| Type | |
| Formula | C28H32N4O3S |
| Weight | Average: 504.65 Monoisotopic: 504.21951208 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
